Kidney-Targeted Epoxyeicosatrienoic Acid Analog, EET-F01, Reduces Inflammation, Oxidative Stress, and Cisplatin-Induced Nephrotoxicity

MLA

John R. Falck, et al. “Kidney-Targeted Epoxyeicosatrienoic Acid Analog, EET-F01, Reduces Inflammation, Oxidative Stress, and Cisplatin-Induced Nephrotoxicity.” International Journal of Molecular Sciences, Mar. 2021. EBSCOhost, https://doi.org/10.3390/ijms22062793.

APA

John R. Falck, Adeniyi Michael Adebesin, Guan Chen, Anna Burkhan, Abdul H. Khan, & John D. Imig. (2021). Kidney-Targeted Epoxyeicosatrienoic Acid Analog, EET-F01, Reduces Inflammation, Oxidative Stress, and Cisplatin-Induced Nephrotoxicity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms22062793

Chicago

John R. Falck, Adeniyi Michael Adebesin, Guan Chen, Anna Burkhan, Abdul H. Khan, and John D. Imig. 2021. “Kidney-Targeted Epoxyeicosatrienoic Acid Analog, EET-F01, Reduces Inflammation, Oxidative Stress, and Cisplatin-Induced Nephrotoxicity.” International Journal of Molecular Sciences, March. doi:10.3390/ijms22062793.